N
NextCell Pharma AB
F:65G
NextCell Pharma AB
F:65G
Price:
0.0904
EUR
1.69%
Market Closed
Market Cap:
€10.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
NextCell Pharma AB
F:65G
|
SE |
|
T
|
Technip Energies NV
OTC:THNPY
|
FR |
|
MTN Group Ltd
F:LL6
|
ZA |
|
B
|
Bridgestone Corp
SWB:BGT
|
JP |
|
M
|
Markel Corp
LSE:0JYM
|
US |
|
Orexo AB
F:C5G
|
SE |
|
B
|
Bank CIMB Niaga Tbk PT
XMUN:NKX
|
ID |
|
N
|
Naturgy Energy Group SA
SWB:GAN
|
ES |
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
CH |
|
C
|
Constellation Software Inc
XBER:W9C
|
CA |
|
B
|
Baozun Inc
XBER:2BZA
|
CN |
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
Atlanta Braves Holdings Inc
F:E45
|
US |
|
B
|
Brookdale Senior Living Inc
XBER:B7S
|
US |
|
P
|
Parsons Corp
F:59P
|
US |
|
P
|
Prudential PLC
XBER:PRU
|
UK |
|
N
|
National Vision Holdings Inc
SWB:7NV
|
US |
|
B
|
Becton Dickinson and Co
F:BOX
|
US |
Multiples-Based Value
The Multiples-Based Value for NextCell Pharma AB (65G) under the Base Case is hidden EUR. Compared with the current market price of 0.0904 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
65G Multiples-Based Value
LOCKED
